How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,595 results for

Intrauterine Device

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008–2012 (PubMed)

The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008–2012 Unplanned pregnancy is a significant problem in Australia. Local data pertaining to use of the levonorgestrel-releasing intra-uterine device (LNG-IUD), and associated factors are limited. The aim of this analysis was to calculate prescribing rates of the LNG-IUD in Australia, including trends in prescribing and associations with socio-demographic factors, in order to increase understanding regarding

Full Text available with Trip Pro

2018 BMC women's health

82. Why did the Japanese Government take so long to approve the intrauterine contraceptive device? (PubMed)

Why did the Japanese Government take so long to approve the intrauterine contraceptive device? While the majority of East Asian countries embraced the modern intrauterine device (IUD) during the 1960s, the sale and distribution of the IUD in Japan was not authorized until 1974. In this paper, I address why the Japanese Government took so long to permit the use of the IUD. Firstly, I examine scientific debates in Japan during the early 1950s on the efficacy of the IUD and associated health risks

Full Text available with Trip Pro

2018 Reproductive Biomedicine & Society Online

83. The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008-2012. (PubMed)

The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008-2012. Unplanned pregnancy is a significant problem in Australia. Local data pertaining to use of the levonorgestrel-releasing intra-uterine device (LNG-IUD), and associated factors are limited. The aim of this analysis was to calculate prescribing rates of the LNG-IUD in Australia, including trends in prescribing and associations with socio-demographic factors, in order to increase understanding regarding

Full Text available with Trip Pro

2018 BMC Women's Health

84. Intracranial hypertension after Chiari decompression resolving after removal of a levonorgestrel-releasing intrauterine device: case report. (PubMed)

Intracranial hypertension after Chiari decompression resolving after removal of a levonorgestrel-releasing intrauterine device: case report. Levonorgestrel-releasing intrauterine devices (LIUDs) are thought to release this progestin locally in the uterus to limit side effects. Authors here present a case of treatment-refractory hydrocephalus and pseudomeningocele (PMC), both of which fully resolved after LIUD removal.A 35-year-old woman with an implanted LIUD developed symptomatic PMC

2018 Journal of Neurosurgery

85. Experience with Intrauterine Device Insertion in Never Sexually Active Adolescents: A Retrospective Cohort Study. (PubMed)

Experience with Intrauterine Device Insertion in Never Sexually Active Adolescents: A Retrospective Cohort Study. Intrauterine devices can offer both contraceptive and noncontraceptive benefits to never sexually active adolescents. There are increasing data on intrauterine device use in adolescents; however, most data on intrauterine devices in adolescents are related to contraceptive use. There is very limited literature on intrauterine device placement in adolescents who have never been (...) sexually active.The objective of the study was to compare intrauterine device insertion success between never sexually active and sexually active cohorts.We performed a retrospective chart review of patients aged 10-20 years with attempted intrauterine device insertion at a children's hospital between October 2015 and September 2017.A total of 210 patients were included, of whom 82 were never sexually active. Never sexually active adolescents were younger at insertion (15.6 vs 16.7 years, P < .001

2018 American Journal of Obstetrics and Gynecology

86. Clioquinol is a promising preventive morphological switching compound in the treatment of Candida infections linked to the use of intrauterine devices. (PubMed)

Clioquinol is a promising preventive morphological switching compound in the treatment of Candida infections linked to the use of intrauterine devices. Candida biofilm infections are frequently linked to the use of biomaterials and are of clinical significance because they are commonly resistant to antifungals. Clioquinol is an antiseptic drug and is effective against multidrug-resistant Candida. We investigated the effect of clioquinol and two other 8-hydroxyquinoline derivatives on Candida (...) biofilm.The ability to inhibit biofilm formation, inhibit preformed biofilm and remove established biofilms was evaluated using in vitro assays on microtitre plates. The action of clioquinol on biofilm in intrauterine devices (IUDs) was also investigated, describing the first protocol to quantify the inhibitory action of compounds on biofilms formed on IUDs.Clioquinol was found to be the most effective 8-hydroxyquinoline derivative among those tested. It prevented more than 90 % of biofilm formation

2018 Journal of Medical Microbiology

87. Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques

Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03724708 Recruitment Status : Recruiting First Posted : October 30, 2018 Last Update

2018 Clinical Trials

88. A Decision Analysis Model of 1-Year Effectiveness of Intended Postplacental Compared With Intended Delayed Postpartum Intrauterine Device Insertion. (PubMed)

A Decision Analysis Model of 1-Year Effectiveness of Intended Postplacental Compared With Intended Delayed Postpartum Intrauterine Device Insertion. To compare, using decision analysis methodology, the 1-year probability of pregnancy after intended postplacental intrauterine device (IUD) insertion with intended delayed insertion at an outpatient postpartum visit (delayed postpartum placement).We developed an evidence-based decision model with the primary outcome of 1-year probability

2018 Obstetrics and Gynecology

89. Steroid reservoir loss during removal of perforated Levonorgestrel 52mg intrauterine device. (PubMed)

Steroid reservoir loss during removal of perforated Levonorgestrel 52mg intrauterine device. A 22-year-old G1P1 Caucasian female had hysteroscopic removal of a perforated intrauterine device during which the steroid reservoir of the intrauterine device was lost. Isolated steroid reservoirs are radiolucent on plain film radiography. We located the reservoir in the peritoneal cavity with magnetic resonance imaging and removed it via laparoscopy.Copyright © 2018 Elsevier Inc. All rights reserved.

2018 Contraception

90. The intrauterine device as emergency contraception: How much do young women know? (PubMed)

The intrauterine device as emergency contraception: How much do young women know? Unprotected intercourse is common, especially among teens and young women. Access to intrauterine device (IUD) as emergency contraception (EC) can help interested patients more effectively prevent unintended pregnancy and can also offer ongoing contraception. This study evaluated young women's awareness of IUD as EC and interest in case of need.We conducted a secondary analysis of data from young women aged 18

2018 Contraception

91. Satisfaction With the Intrauterine Device Insertion Procedure Among Adolescent and Young Adult Women. (PubMed)

Satisfaction With the Intrauterine Device Insertion Procedure Among Adolescent and Young Adult Women. To evaluate satisfaction with intrauterine device (IUD) insertion procedures among adolescent and young adult women.This secondary analysis of data from a multisite, single-blind, sham-controlled randomized trial of women having a levonorgestrel 13.5-mg IUD inserted enrolled participants from March 2015 through July 2016 at three family planning clinics in Philadelphia, Pennsylvania. Eligible

Full Text available with Trip Pro

2018 Obstetrics and Gynecology

92. ACOG Committee Opinion No. 735 Summary: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. (PubMed)

ACOG Committee Opinion No. 735 Summary: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. The phenomenon of adolescent childbearing is complex and far reaching, affecting not only the adolescents but also their children and their community. The prevalence and public health effect of adolescent pregnancy reflect complex structural social problems and an unmet need for acceptable and effective contraceptive methods in this population. In 2006-2010, 82 (...) % of adolescents at risk of unintended pregnancy were currently using contraception, but only 59% used a highly effective method, including any hormonal method or intrauterine device. Long-acting reversible contraceptives (LARC) have higher efficacy, higher continuation rates, and higher satisfaction rates compared with short-acting contraceptives among adolescents who choose to use them. Complications of intrauterine devices and contraceptive implants are rare and differ little between adolescents and women

2018 Obstetrics and Gynecology

93. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. (PubMed)

ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. The phenomenon of adolescent childbearing is complex and far reaching, affecting not only the adolescents but also their children and their community. The prevalence and public health effect of adolescent pregnancy reflect complex structural social problems and an unmet need for acceptable and effective contraceptive methods in this population. In 2006-2010, 82 (...) % of adolescents at risk of unintended pregnancy were currently using contraception, but only 59% used a highly effective method, including any hormonal method or intrauterine device. Long-acting reversible contraceptives (LARC) have higher efficacy, higher continuation rates, and higher satisfaction rates compared with short-acting contraceptives among adolescents who choose to use them. Complications of intrauterine devices and contraceptive implants are rare and differ little between adolescents and women

2018 Obstetrics and Gynecology

94. Case Report: Cervicovaginal Co-Colonization with <i>Entamoeba gingivalis</i> and <i>Entamoeba polecki</i> in Association with an Intrauterine Device. (PubMed)

Case Report: Cervicovaginal Co-Colonization with Entamoeba gingivalis and Entamoeba polecki in Association with an Intrauterine Device. Amoebic trophozoites were identified in the cervicovaginal smear of a U.S. patient without travel history at the time of intrauterine device (IUD) removal. Subsequent morphologic analysis and DNA sequencing identified a mixed cervicovaginal colonization of the female genital tract with both Entamoeba gingivalis and Entamoeba polecki in association

2018 American Journal of Tropical Medicine & Hygiene

95. One year continuation of post-partum intrauterine contraceptive device: findings from a retrospective cohort study in India. (PubMed)

One year continuation of post-partum intrauterine contraceptive device: findings from a retrospective cohort study in India. To evaluate outcomes of a national postpartum (within 48 h of delivery) copper intrauterine device placement (PPCuIUD) program in six "high-focus states" with high unmet family planning need in India.We identified high-volume district hospitals that provided PPCuIUD in six (Bihar, Jharkhand, Uttar Pradesh, Uttarakhand, Madhya Pradesh and Chhattisgarh) Indian states (two

2018 Contraception

96. Comparing the Efficacy of Intrauterine Balloon and Intrauterine Contraceptive Device for the Therapy of Uterine Adhesion

Comparing the Efficacy of Intrauterine Balloon and Intrauterine Contraceptive Device for the Therapy of Uterine Adhesion Comparing the Efficacy of Intrauterine Balloon and Intrauterine Contraceptive Device for the Therapy of Uterine Adhesion - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. Comparing the Efficacy of Intrauterine Balloon and Intrauterine Contraceptive Device for the Therapy of Uterine Adhesion The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02867202 Recruitment Status : Unknown Verified

2016 Clinical Trials

97. Efficacy of Intrauterine Lidocaine and Naproxen for Pain Control With Intrauterine Device Insertion

Efficacy of Intrauterine Lidocaine and Naproxen for Pain Control With Intrauterine Device Insertion Efficacy of Intrauterine Lidocaine and Naproxen for Pain Control With Intrauterine Device Insertion - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Efficacy of Intrauterine Lidocaine and Naproxen for Pain Control With Intrauterine Device Insertion The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02769247 Recruitment Status : Completed First Posted : May 11, 2016 Results First Posted : November 8, 2018

2016 Clinical Trials

98. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception. (PubMed)

Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception. The aim of this study was to compare the safety, bleeding pattern, effects, side-effects, complications and 6-month continuity rates of levonorgestrel-bearing intrauterine system (LNG-IUS) with conventional copper intrauterine device (Cu-IUD) inserted immediately after voluntary termination of pregnancy up to 10 weeks of gestation.One hundred women who underwent voluntary (...) %, respectively. In LNG-IUS users, the incidence of amenorrhea and the number of spotting days were higher and hemoglobin increased throughout the follow-up period. The side-effects related to both methods were not different from interval insertions.Immediate post-abortion intrauterine contraception with Cu-IUD or LNG-IUS is a safe, reliable method. The incidence of side-effects is similar, and there is only a slightly higher rate of expulsion but an acceptable rate of method continuation.© 2015 Japan Society

2016 The journal of obstetrics and gynaecology research

99. IUB? SCu300A intrauterine device for contraception

IUB? SCu300A intrauterine device for contraception IUB™ SCu300A intrauterine device for contraception IUB™ SCu300A intrauterine device for contraception NIHR HSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSC. IUB™ SCu300A intrauterine device for contraception. Birmingham: NIHR Horizon Scanning Centre (NIHR HSC). Horizon (...) Scanning Review. 2013 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Contraception; Females; Intrauterine Devices Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health&Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United

2013 Health Technology Assessment (HTA) Database.

100. Authors' response to 'Comment on 'Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial' '. (PubMed)

Authors' response to 'Comment on 'Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial' '. 29018110 2018 07 05 2045-2098 43 4 2017 Oct The journal of family planning and reproductive health care J Fam Plann Reprod Health Care Authors' response to 'Comment on 'Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic (...) ; tess@lawrie.com. eng Letter England J Fam Plann Reprod Health Care 101087687 1471-1893 human immunodeficiency virus intrauterine devices long-acting progestogens Competing interests: None declared. 2017 07 10 2017 07 11 2017 10 12 6 0 2017 10 12 6 0 2017 10 12 6 1 ppublish 29018110 jfprhc-2017-101864 10.1136/jfprhc-2017-101864

2017 The Journal of Family Planning and Reproductive Health Care

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>